Bionano Genomics Inc (NASDAQ:BNGO) price closed lower on Monday, April 15, dropping -11.00% below its previous close.
A look at the daily price movement shows that the last close reads $0.98. The company’s 5Y monthly beta was ticking 2.37. Taking into account the 52-week price action we note that the stock hit a 52-week high of $11.80 and 52-week low of $0.95. The stock subtracted -14.71% on its value in the past month.
Bionano Genomics Inc, which has a market valuation of $53.27 million, is expected to release its quarterly earnings report May 07, 2024 – May 13, 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give BNGO a short term outlook of 100% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 100% Sell.
The overview shows that BNGO’s price is at present -16.11% off the SMA20 and -22.48% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 29.96, with weekly volatility standing at 9.09%. The indicator jumps to 7.95% when calculated based on the past 30 days. Bionano Genomics Inc (NASDAQ:BNGO)’s beta value is holding at 2.39, while the average true range (ATR) indicator is currently reading 0.09.
An analysis of the Bionano Genomics Inc (NASDAQ:BNGO) stock in terms of its daily trading volume indicates that the 3-month average is 1.60 million.
Current records show that the company has 61.23M in outstanding shares. The insiders’ percentage holdings are 1.07% of outstanding shares while the percentage share held by institutions stands at 10.09%. But the -53.97% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
